Accelerated Pharma (Accelerated Pharma) Other Current Liabilities : $0.40 Mil (As of Mar. 2017)

View and export this data going back to 2016. Start your Free Trial

What is Accelerated Pharma Other Current Liabilities?

Accelerated Pharma's other current liabilities for the quarter that ended in Mar. 2017 was $0.40 Mil.

Accelerated Pharma's quarterly other current liabilities declined from Sep. 2016 ($0.38 Mil) to Dec. 2016 ($0.35 Mil) but then increased from Dec. 2016 ($0.35 Mil) to Mar. 2017 ($0.40 Mil).

Accelerated Pharma's annual other current liabilities increased from Dec. 2014 ($0.26 Mil) to Dec. 2015 ($0.38 Mil) but then declined from Dec. 2015 ($0.38 Mil) to Dec. 2016 ($0.35 Mil).

Accelerated Pharma Other Current Liabilities Historical Data

The historical data trend for Accelerated Pharma's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerated Pharma Other Current Liabilities Chart

Accelerated Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Other Current Liabilities

Accelerated Pharma Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Other Current Liabilities	Get a 7-Day Free Trial			-	-	-	-	-

Accelerated Pharma Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Accelerated Pharma Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Accelerated Pharma's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Accelerated Pharma (Accelerated Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Accelerated Pharma Inc, is a Delaware corporation organized on May 12, 2014. It is a biopharmaceutical company focused on utilizing its genomic technology to enhance the development and commercialization of pharmaceutical products. Its lead product candidate is Picoplatin, a new generation platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications.

Accelerated Pharma (Accelerated Pharma) Headlines

No Headlines